QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Toronto
State: Ontario
Zip:
Country: Canada
Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents (GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2018 | Grant | 1 | - |
Ontario Brain Institute Ontario Brain Institute |
5/2021 | Seed Round | 5 | $3M |
Creative Destruction Lab (CDL) FACIT MEDTEQ+ Ontario Brain Institute Ontario Centre of Innovation Creative Destruction Lab (CDL) FACIT MEDTEQ+ Ontario Brain Institute Ontario Centre of Innovation |
4/2019 | Seed Round | 4 | - |
Creative Destruction Lab (CDL) FACIT Ramen Ventures UTEST Creative Destruction Lab (CDL) FACIT Ramen Ventures UTEST |
1/2020 | Seed Round | 1 | - |
FACIT FACIT |
1/2020 | Seed Round | 1 | - |
FACIT FACIT |
4/2019 | Seed Round | 4 | - |
Creative Destruction Lab (CDL) FACIT Ramen Ventures UTEST Creative Destruction Lab (CDL) FACIT Ramen Ventures UTEST |
10/2018 | Grant | 1 | - |
Ontario Brain Institute Ontario Brain Institute |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|